NASDAQ · STOCK
Bank of New York Mellon
$137.19
52W $91.96 – $149.97
65/100
—
15.8
1.06
Price History (6M)
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Executive Summary
6 analysts weighed in with 50% agreement on a bullish lean. Growth Analyst: Revenue growing 284.6% YoY -- genuine top-line momentum. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
- Daily trend: uptrend.
- Weekly trend: uptrend.
- Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Stochastic RSI (97.6) confirms overbought conditions.
- MACD histogram is negative (-0.015) — bearish momentum.
- Risk/reward is unfavorable: 18.5% downside vs 1.4% upside.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
65/100
Agreement
50%
Analysts
6
Conviction
Contested
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
Growth Analyst
bullish
85
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 284.6% YoY -- genuine top-line momentum
Technical Analyst
neutral
57
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
47
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.33 across 3 articles, 14d)
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
68.2
Neutral
MACD Histogram
-0.015
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Support
$111.78
Resistance
$139.09
Bollinger %B
0.93
Inside Bands
Price vs Moving Averages
EMA 9
$135.29
Above
EMA 21
$133.54
Above
EMA 50
$129.26
Above
EMA 200
$115.83
Above
Fundamental Analysis
Valuation
96
Growth
100
Profitability
60
Financial Health
65
Valuation
P/E Ratio
15.8×
P/B Ratio
1.83×
PEG Ratio
—
Dividend Yield
1.55%
52W High
$149.97
52W Low
$91.96
Quality & Growth
ROE
1348.0%
ROA
121.0%
Gross Margin
—
Operating Margin
2654.2%
Revenue Growth YoY
+28455.9%
Debt / Equity
1.20
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 15.8 (inexpensive relative to a 15-40x range); Price-to-book of 1.8x; Revenue growth (YoY) of 284.6%; EPS growth (YoY) of 31.5%; Return on equity of 13.5%; Return on assets of 1.2%; Net margin of 21.2%; Debt-to-equity of 1.20; Earnings-history trend unavailable; growth based on TTM year-over-year only.
Key Risks
- Stochastic RSI (97.6) confirms overbought conditions.
- MACD histogram is negative (-0.015) — bearish momentum.
- Risk/reward is unfavorable: 18.5% downside vs 1.4% upside.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full BK Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile